TY - JOUR
T1 - Sex differences in clinical characteristics of migraine and its burden
T2 - a population-based study
AU - Chalmer, Mona Ameri
AU - Kogelman, Lisette J.A.
AU - Callesen, Ida
AU - Christensen, Charlotte Grønvold
AU - Techlo, Tanya Ramdal
AU - Møller, Peter L.
AU - Davidsson, Olafur B.
AU - Olofsson, Isa A.
AU - Schwinn, Michael
AU - Mikkelsen, Susan
AU - Dinh, Khoa Manh
AU - Nielsen, Kaspar
AU - Topholm, Mie
AU - Erikstrup, Christian
AU - Ostrowski, Sisse Rye
AU - Pedersen, Ole Birger
AU - Hjalgrim, Henrik
AU - Banasik, Karina
AU - Burgdorf, Kristoffer S.
AU - Nyegaard, Mette
AU - Olesen, Jes
AU - Hansen, Thomas Folkmann
AU - DBDS Genomic Consortium
N1 - Funding Information:
The study was financed by a grant from Candys Foundation, the CEHEAD program (J.O.) and the Research Funding Pool at Rigshospitalet (M.A.C.). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
PY - 2023/6
Y1 - 2023/6
N2 - Background and purpose: Understanding migraine in a sex-specific manner is crucial for improving clinical care, diagnosis and therapy for both females and males. Here, data on sex differences are provided in the presentation of migraine in a large European-based population cohort, which is representative of the general population. Methods: A population-based study of 62,672 Danish blood donors (both present and previous donors), of whom 12,658 had migraine, was performed. All participants completed a 105-item diagnostic migraine questionnaire sent via an electronic mailing system (e-Boks) between May 2020 and August 2020. The questionnaire allowed for correct diagnosis of migraine according to the International Classification of Headache Disorders, third edition. Results: The migraine questionnaire was in-cohort validated and had a positive predictive value of 97% for any migraine, a specificity of 93% and a sensitivity of 93%. There were 9184 females (mean age 45.1 years) and 3434 males (mean age 48.0 years). The 3-month prevalence of migraine without aura was 11% in females and 3.59% in males. The 3-month prevalence of migraine with aura was 1.72% in females and 1.58% in males. In females, the age-related 3-month prevalence of migraine without aura increased markedly during childbearing age. In males, migraine both with and without aura showed less age variation. Females had a higher frequency of migraine attacks (odds ratio [OR] 1.22) but a lower frequency of non-migraine headaches (OR = 0.35). Females also had a greater intensity of pain, more unilateral and pulsatile pain, and exacerbation by physical activity (OR = 1.40–1.49) as well as more associated symptoms (OR = 1.26–1.98). Females carried 79% of the total migraine disease burden, which was almost exclusively driven by migraine without aura (77%), whilst there was no sex difference in the disease burden of migraine with aura. Conclusion: Females have more severe disease, resulting in a much higher migraine disease burden than indicated by prevalence alone.
AB - Background and purpose: Understanding migraine in a sex-specific manner is crucial for improving clinical care, diagnosis and therapy for both females and males. Here, data on sex differences are provided in the presentation of migraine in a large European-based population cohort, which is representative of the general population. Methods: A population-based study of 62,672 Danish blood donors (both present and previous donors), of whom 12,658 had migraine, was performed. All participants completed a 105-item diagnostic migraine questionnaire sent via an electronic mailing system (e-Boks) between May 2020 and August 2020. The questionnaire allowed for correct diagnosis of migraine according to the International Classification of Headache Disorders, third edition. Results: The migraine questionnaire was in-cohort validated and had a positive predictive value of 97% for any migraine, a specificity of 93% and a sensitivity of 93%. There were 9184 females (mean age 45.1 years) and 3434 males (mean age 48.0 years). The 3-month prevalence of migraine without aura was 11% in females and 3.59% in males. The 3-month prevalence of migraine with aura was 1.72% in females and 1.58% in males. In females, the age-related 3-month prevalence of migraine without aura increased markedly during childbearing age. In males, migraine both with and without aura showed less age variation. Females had a higher frequency of migraine attacks (odds ratio [OR] 1.22) but a lower frequency of non-migraine headaches (OR = 0.35). Females also had a greater intensity of pain, more unilateral and pulsatile pain, and exacerbation by physical activity (OR = 1.40–1.49) as well as more associated symptoms (OR = 1.26–1.98). Females carried 79% of the total migraine disease burden, which was almost exclusively driven by migraine without aura (77%), whilst there was no sex difference in the disease burden of migraine with aura. Conclusion: Females have more severe disease, resulting in a much higher migraine disease burden than indicated by prevalence alone.
KW - blood donors
KW - burden
KW - migraine
KW - population-based study
KW - sex differences
KW - sex stratification
KW - Migraine with Aura/diagnosis
KW - Headache/epidemiology
KW - Humans
KW - Middle Aged
KW - Male
KW - Sex Characteristics
KW - Migraine without Aura
KW - Female
KW - Surveys and Questionnaires
UR - http://www.scopus.com/inward/record.url?scp=85151278558&partnerID=8YFLogxK
U2 - 10.1111/ene.15778
DO - 10.1111/ene.15778
M3 - Journal article
C2 - 36905094
AN - SCOPUS:85151278558
SN - 1351-5101
VL - 30
SP - 1774
EP - 1784
JO - European Journal of Neurology
JF - European Journal of Neurology
IS - 6
ER -